id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2019-N-5464-0028,FDA,FDA-2019-N-5464,Center for Drug Evaluation and Research Office of New Drugs Novel Excipient Review Pilot Program,Notice,Announcement,2021-09-08T04:00:00Z,2021,9,2021-09-08T04:00:00Z,2021-12-08T04:59:59Z,2021-10-05T01:00:33Z,2021-19335,0,0,0900006484d5ee1f
FDA-2019-N-5464-0001,FDA,FDA-2019-N-5464,Novel Excipient Review Program Proposal; Request for Information and Comments,Notice,60 Day Proposed Information Collection,2019-12-05T05:00:00Z,2019,12,2019-12-05T05:00:00Z,2020-02-04T04:59:59Z,2020-02-04T02:01:22Z,2019-26266,0,0,09000064841e74ea